首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備 DDS

市場調查報告書

商品編碼

2075225

皮下給藥市場：依易用性、疾病適應症、給藥系統、通路和地區分類。

Subcutaneous Drug Delivery Market, By Usability, By Disease Indication, By Delivery SystemBy Distribution Channel, and By Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，皮下給藥市場規模將達到 157 億美元，到 2033 年將達到 304.1 億美元。預計從 2026 年到 2033 年，該市場將以 9.9% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	157億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.90%	2033年市場規模預測：	304.1億美元

預填充式注射器和自動注射器的技術創新與發展正在推動市場成長。例如，2020年6月，德國初級包裝製造商Gellesheimer推出了不含金屬的「Lure Lock Gx RTF注射器」。本產品不使用鎢，是生物技術生產的活性成分的理想初級包裝材料，能有效避免金屬污染。

此外，醫療設備製造商IpsoMed於2022年3月開發了“YpsoMate SmartPilot”，這是一款可重複使用的附件，適用於其專有的“YpsoMate”胰島素筆。此附件旨在簡化注射流程，只需兩個步驟即可完成。它配備感測器和記憶器，並可與應用程式配合使用，顯示注射時間和劑量。胰島素筆還能提供使用者音訊和視覺回饋。此外，該應用程式還能在需要注射胰島素時提醒使用者。

市場動態

在預測期內，產品的法規核准預計將推動市場成長。例如，2023年3月6日，全球生物相似藥公司Coherus BioSciences, Inc.宣布，美國食品藥物管理局（FDA）已批准UDENYCA（Pegfilgrastim）的單劑量預填充充式自動注射器製劑。 UDENYCA自動注射器設計簡潔易用，適用於診所和家庭護理。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球皮下注射藥物市場主要公司的概況：公司概況、財務表現、產品系列、市場佔有率、分銷策略、重大發展、策略和未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
全球皮下藥物輸送市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球皮下藥物輸送市場中使用的各種策略矩陣來簡化決策過程。

概述
北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

公司簡介
- Becton Dickinson and Company
- Novo Nordisk A/S
- Johnson & Johnson.
- Novartis International AG
- Amgen, Inc
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche AG.
- Consort Medical plc.
- LaVision Biotec GmbH
- Eli Lilly and Company
- Merck & Co., Inc.
- Insulet Corporation
- West Pharmaceutical Services, Inc.
- Gerresheimer AG.

第11章

參考
調查方法

簡介目錄

Product Code: CMI2933

Subcutaneous Drug Delivery Market is estimated to be valued at USD 15.70 Bn in 2026 and is expected to reach USD 30.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 15.70 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.90%	2033 Value Projection:	USD 30.41 Bn

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.

Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.

Market Dynamics

Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global subcutaneous drug delivery market based on the following parameters-company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

Detailed Segmentation:

Global Subcutaneous Drug Delivery Market, Usability
Disposable
Reusable
Global Subcutaneous Drug Delivery Market, Disease Indication
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
Others
Global Subcutaneous Drug Delivery Market, Delivery System
Prefilled Syringes
Autoinjector
- Spring Type
- Motorized Type
- Wearable Type
Pen Injectors
- Disposable
- Reusable
- Syringes (Injector)
Others (pump, etc.)
Global Subcutaneous Drug Delivery Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Subcutaneous Drug Delivery Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Becton Dickinson and Company,
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novo Nordisk A/S,
Johnson & Johnson
Novartis International AG
Amgen, Inc.
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche AG.,
Consort Medical plc,
Eli Lilly and Company
Merck & Co., Inc.
Insulet Corporation,
West Pharmaceutical Services, Inc.
Gerresheimer AG

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Usability
- Market Snapshot, By Disease Indication
- Market Snapshot, By Delivery System
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Merger, Acquisition, and Collaborations
Product Launch
Regulatory Scenario
PEST Analysis

4. Global Subcutaneous Drug Delivery

Economic Impact
Impact on Supply and Demand

5. Global Subcutaneous Drug Delivery Market, By Usability, 2021€"2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Reusable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

6. Global Subcutaneous Drug Delivery Market, By Disease Indication , 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Auto-immune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Oncology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Hormonal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Allergy & Infectious Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Ophthalmic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Global Subcutaneous Drug Delivery Market, By Delivery System, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Auto injector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Pen Injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Disposable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Others (pump, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

8. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Billion)

9. Global Subcutaneous Drug Delivery Market, By Region, 2021€"2033, (US$ Billion)

Overview
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022€"2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Usability , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021€" 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Becton Dickinson and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novo Nordisk A/S
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Johnson & Johnson.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novartis International AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Amgen, Inc
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- F. Hoffmann-La Roche AG.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Consort Medical plc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- LaVision Biotec GmbH
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Eli Lilly and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Insulet Corporation
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- West Pharmaceutical Services, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Gerresheimer AG.
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies